Clinical Trial Update: Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial completed comparing the pharmacokinetics of NVP-1205 with the coadministration of Rosuvastatin and Ezetimibe in individuals with dyslip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• NVP-1205 (NVP-1205)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: NVP Healthcare | Conditions: Dyslipidemia | Phase 1 | Status: COMPLETED